risk

Why Biogen is purposefully becoming more risk averse, according to Biogen’s CEO
Stat
Fri, 10/20/23 - 09:57 am
Biogen
Christopher Viehbacher
Pharma CEOs
risk
FDA outlines risk-based approach to monitoring clinical trials
RAPS.org
Tue, 04/11/23 - 07:19 pm
clinical trials
regulatory
FDA
risk
Barron exhorts GSK scientists to take 'smart risks'
Fierce Biotech
Mon, 07/22/19 - 09:51 am
GSK
drug development
R&D
Hal Barron
risk
Balancing Benefit and Risk in Medical Device Regulation
FDA Law Blog
Wed, 02/20/19 - 09:52 am
devices
risk
regulatory
FDA